Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the SVB Leerink New Treatments Focused on Women’s Health Conference, New York
On the 10 October, Dr Mary Kerr will be attending and presenting at the SVB Leerink conference focusing on women’s health in New York. During the presentation, Dr Kerr will be presenting the latest available update on KaNDy Therapeutics breakthrough non-hormonal treatment NT-814 for multiple symptoms of the menopause.